Dyno Therapeutics: Empowering Patients with Genetic Agency

For the first time in human history, we can diagnose thousands of genetic diseases—often for under $1,000—but we still can't treat most of them. The problem isn't understanding what's broken; it's delivering the fix to the right cells. Eric Kelsic, CEO of Dyno Therapeutics, joins a16z's Jorge Conde to explain how AI-designed protein shells are solving gene therapy's delivery crisis. They explore why Huntington's patients can now get 15 extra years of healthy life, how Dyno inverted the liver-to-brain delivery ratio by 1000x, and why capsids evolved by nature are now being designed by machine learning models trained on millions of variants. Eric introduces the concept of genetic agency—humanity's first-ever ability to take action at the DNA level—and details why solving delivery for common diseases will make ultra-rare disease treatments economically viable. Plus: what happens when gene therapy requires neurosurgery today but could be a simple injection tomorrow, why recent deaths in clinical trials prove we need better technology now, and how genetic medicine could become as routine as surgery within our lifetimes. Resources: Follow Eric on X: Follow Jorge on X: Learn more about GATC 2025: Stay Updated: If you enjoyed this episode, be sure to like,

You can listen to Dyno Therapeutics: Empowering Patients with Genetic Agency online on Radio and Podcast. Open the player on this page to stream the available audio.

Dyno Therapeutics: Empowering Patients with Genetic Agency is an episode from Bio Eats World by a16z.

This episode is 00:47:28 long.

This episode was published on Nov 7, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Bio Eats World when more episodes are available from the podcast feed.